Novo Nordisk Soars, Albermarle Climbs , Huntington Ingall Rises
On this episode of Stock Movers:- Novo Nordisk (NOVOB) won approval to sell a pill version of its blockbuster obesity shot Wegovy in the US, a crucial step in its effort to defend its market share from rival Eli Lilly (LLY). The shares soared by as much as 11% in Copenhagen, the biggest intraday gain since August. Novo has fallen by almost half this year amid concern about the Danish drugmaker’s ability to compete in the obesity market it pioneered.- Copper hit a fresh all-time high above $12,000 a ton due to severe mine outages and trade dislocations linked to US President Donald…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.